期刊文献+

壳聚糖在软骨组织工程中的应用 被引量:12

APPLICATION OF CHITOSAN IN CARTILAGE TISSUE ENGINEERING
下载PDF
导出
摘要 目的对高分子生物材料壳聚糖在软骨组织工程中的应用现状进行综述。方法广泛查阅近年来有关壳聚糖在组织工程中应用的文献,综合分析,讨论其生物相容性、可降解性及其应用。结果壳聚糖具有良好的生物相容性、可降解性,除能提供细胞生长所需的三维支架作用外,还能提供类似软骨基质的细胞外环境,维持细胞表型及功能。结论壳聚糖在软骨组织工程中具有良好的应用前景。 Objective To introduce the application of polymer material, chitosan, in the cartilage tissue engineering. Methods The recent original articles on the application of chitosan in cartilage tissue engineering were extensively reviewed. The biocompatibility and biodegradation characters of chitosan and its application were analysed. Results Chitosan has a high degree of biocompatibility and a favorable chondrogenic characteristic. It can support the maintenance of the phenotypic morphology of chondrocytes besides being used as a scaffold for cell growth. Conclusion The perspect of the application of chitosan in cartilage tissue engineering is hopeful.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2005年第10期831-834,共4页 Chinese Journal of Reparative and Reconstructive Surgery
基金 国家自然科学基金资助项目(30270393) 广东省科技计划资助项目(2003A302102)
关键词 壳聚糖 组织工程软骨 应用 Chitosan Tissue engineered cartilage Application
  • 相关文献

参考文献30

  • 1Amiel D, Toyoguchi T, Kobayashi K, et al. Long-term effect of sodium hyaluronate (Hyalgan) on osteoarthritis progression in a rabbit model. Osteoarthritis Cartilage, 2003, 11(9): 636-643.
  • 2Hulmes DJ, Marsden ME, Strachan RK, et al. Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content. Osteoarthritis Cartilage, 2004, 12(3): 232-238.
  • 3Suh JK, Matthew HW. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials, 2000, 21(24): 2589-2598.
  • 4张建湘,汤健,徐斌,蔡克勤,马卫东,方月娥,史天义,魏俊.壳聚糖钉固定兔胫骨近端截骨的实验研究[J].生物医学工程学杂志,1998,15(2):179-182. 被引量:28
  • 5Lahiji A, Sohrabi A, Hungerford DS, et al. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res, 2000, 51(4): 586-595.
  • 6Lu JX, Prudhommeaux F, Meunier A, et al. Effects of chitosan on rat knee cartilages. Biomaterials, 1999, 20(20): 1937-1944.
  • 7高萍,鲍世兰,刘欣,史弘道.不同交联度的医用级壳聚糖的降解研究[J].生物医学工程与临床,2002,6(4):188-190. 被引量:6
  • 8Nettles DL, Elder SH, Gilbert JA. Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng, 2002, 8(6): 1009-1016.
  • 9Park JS, Choi SH, Moon IS, et al. Eight-week histological analysis on the effect of chitosan on surgically created one-wall intrabony defects in beagle dogs. J Clin Periodontol, 2003, 30(5): 443-453.
  • 10Yin Y, Ye F, Cui J, et al. Preparation and characterization of macroporous chitosan-gelatin/ beta-tricalcium phosphate composite scaffolds for bone tissue engineering. J Biomed Mater Res, 2003, 67(3): 844-855.

二级参考文献37

  • 1温汉平,孙华蕴,周殿元.化疗药物体外药敏试验(MTT分析法)[J].中国肿瘤临床,1994,21(11):816-817. 被引量:16
  • 2吴德升,赵定麟,何北平,杜晓冰.修复周围神经缺损的组织工程研究[J].生物医学工程学杂志,1997,14(2):108-110. 被引量:20
  • 3Yang L J, Jin L. Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions[ J ]. Clin Orthop,1990, 257: 249-56.
  • 4Kawamura M, Urist MR. Human fibrin is a physiologic delivery system for bone morphogenetic protein[J]. Clin Orthop, 1988, 235: 302-10.
  • 5Maysinger D, Krieglstein K, Filipovic G J, et al. Microencapsulated ciliary nourotrophic factor: physical properties and biological activities[J]. Exp Neurol, 1996, 138(2): 177-88.
  • 6Hiraki Y, Inoue H, Shigeno C. Bone morphogenetic protein (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cell in vitro[J]. J Bone Miner Res, 1991, 6(12): 1373-85.
  • 7Cook SD, Dalton JE, Tan EH, et ol. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions[J]. Spine, 1994, 19(15): 1655-63.
  • 8Groot JD. Carriers that concentrate native bone morphogenetic protein in vivo[J]. Tissue Eng, 1998, 4(4): 337-41.
  • 9Lee EO, Kim JD. Palmitoyl lysozyme-induced stabilization of PE(phosphatidylethanolamine) liposomes and their interaction with Candida albicans[J]. J Biochem, 1995, 117(1): 54-8.
  • 10Rodriguez ML, Holgado MA, Sanchez LC, et al. Alginatc/chitosan particulate systems for sodium diclofenac release[J]. Int J Pharm,2002, 232(1-2): 225-34.

共引文献145

同被引文献148

引证文献12

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部